Title |
The impact of Regional co-payment and National reimbursement criteria on statins use in Italy: an interrupted time-series analysis
|
---|---|
Published in |
BMC Health Services Research, January 2014
|
DOI | 10.1186/1472-6963-14-6 |
Pubmed ID | |
Authors |
Gianfranco Damiani, Bruno Federico, Angela Anselmi, Caterina Bianca Neve Aurora Bianchi, Giulia Silvestrini, Lanfranco Iodice, Pierluigi Navarra, Roberto Da Cas, Roberto Raschetti, Walter Ricciardi |
Abstract |
Statins are among the most commonly prescribed drugs worldwide in the prevention of cardiovascular diseases and their effectiveness is largely acknowledged. The consumption of statins increased four-fold during the 2000-2010 decade in Italy and national and regional control policies were developed. Restrictions to reimbursement were fixed at the national level, whereas co-payment was introduced in some, but not all, regions. The aim of the present study is to assess the impact of such policies on the consumption of statins in Italy between 2001-2007 among outpatients. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 3 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 3 | 100% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Italy | 1 | 3% |
Unknown | 32 | 97% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 7 | 21% |
Student > Master | 4 | 12% |
Student > Ph. D. Student | 4 | 12% |
Student > Postgraduate | 3 | 9% |
Professor | 3 | 9% |
Other | 5 | 15% |
Unknown | 7 | 21% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 8 | 24% |
Pharmacology, Toxicology and Pharmaceutical Science | 6 | 18% |
Economics, Econometrics and Finance | 4 | 12% |
Business, Management and Accounting | 2 | 6% |
Nursing and Health Professions | 1 | 3% |
Other | 2 | 6% |
Unknown | 10 | 30% |